A neurodegenerative vascular burden index and the impact on cognition

Sebastian Heinzel1, Inga Liepelt-Scarfone2, Benjamin Roeben1

  • 1Department of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), University of Tübingen , Tübingen , Germany.

Insights

A new vascular burden index (VBI) based on carotid intima-media thickness (IMT) can identify individuals with increased vascular risk factors. This index is linked to reduced cognitive function, suggesting potential for early detection of neurodegenerative processes.

Area of Science:

  • Neuroscience
  • Cardiology
  • Gerontology

Background:

  • Vascular burden factors impact vascular structure and function, measurable by carotid intima-media thickness (IMT).
  • A multifactorial vascular burden index (VBI) may correlate with early Alzheimer's disease (AD) pathology and preclinical cognitive decline.
  • Identifying individuals at risk for neurodegeneration is crucial for early intervention.

Purpose of the Study:

  • To investigate the multifactorial influence of vascular burden factors on IMT in an elderly cohort at risk for neurodegeneration.
  • To develop and validate a Vascular Burden Index (VBI) based on IMT and its associated risk factors.
  • To assess the impact of the VBI on cognitive performance in preclinical stages of cognitive decline.

Main Methods:

  • A cohort of 1102 elderly individuals at risk for neurodegeneration (TREND study) was analyzed.
  • Vascular factors (obesity, hypertension, smoking, diabetes, atherosclerosis) were selected based on statistical effects on IMT.
  • The VBI's impact on cognitive function was evaluated using the Trail-Making Test (TMT) and CERAD neuropsychological battery.

Main Results:

  • IMT was significantly predicted by age, sex, obesity, hypertension, smoking, diabetes, and atherosclerosis.
  • Individuals with two or more VBI factors had a 3.17 odds ratio for overly increased IMT (≥1.0 mm).
  • The VBI significantly impacted executive control and showed a trend toward decreased global cognitive function, independent of age, sex, and education.

Conclusions:

  • A VBI derived from IMT can identify individuals with increased vascular burden associated with cognitive decline.
  • This VBI may serve as a prodromal marker for neurodegenerative processes and cognitive decline in preclinical Alzheimer's disease.
  • Longitudinal studies are needed to confirm the VBI's value in predicting cognitive decline and AD progression.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
11
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
27
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
685